[{"address1": "50 rue de Dijon", "city": "Daix", "zip": "21121", "country": "France", "phone": "33 3 80 44 75 00", "website": "https://inventivapharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases in France and internationally. The company develops Lanifibranor, a novel pan-peroxisome proliferator-activated receptor agonist that is in the NATiV3 Phase 3 clinical trial to treat adult patients with MASH; and Odiparcil for the treatment of patients with mucopolysaccharidoses. It also develops TGF-\u00df, a pre-clinical program for the treatment of idiopathic pulmonary fibrosis. The company was incorporated in 2011 and is headquartered in Daix, France.", "fullTimeEmployees": 84, "companyOfficers": [{"maxAge": 1, "name": "Dr. Pierre  Broqua Ph.D.", "age": 63, "title": "Co-Founder", "yearBorn": 1962, "fiscalYear": 2024, "totalPay": 429831, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Martine  Zimmermann Pharm.D.", "age": 56, "title": "Executive VP of Regulatory Affairs & Quality Assurance", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 69943, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Andrew  Obenshain", "age": 51, "title": "CEO & Director", "yearBorn": 1974, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jean  Volatier", "age": 60, "title": "Deputy GM & CFO", "yearBorn": 1965, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Alice  Roudot-Ketelers Pharm.D.", "age": 54, "title": "Chief Operating Officer", "yearBorn": 1971, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Eric  Duranson L.L.M.", "age": 51, "title": "General Counsel", "yearBorn": 1974, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Nathalie  Harroy", "age": 58, "title": "Head of Human Resources", "yearBorn": 1967, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Pascaline  Clerc Ph.D.", "age": 45, "title": "Executive Vice President of Strategy & Corporate Affairs", "yearBorn": 1980, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jason A. Campagna M.D., Ph.D.", "age": 59, "title": "President of Research and Development & Chief Medical Officer", "yearBorn": 1966, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 4.92, "open": 4.87, "dayLow": 4.77, "dayHigh": 4.9, "regularMarketPreviousClose": 4.92, "regularMarketOpen": 4.87, "regularMarketDayLow": 4.77, "regularMarketDayHigh": 4.9, "payoutRatio": 0.0, "beta": 0.771, "forwardPE": -3.6799998, "volume": 161511, "regularMarketVolume": 161511, "averageVolume": 318355, "averageVolume10days": 360450, "averageDailyVolume10Day": 360450, "bid": 4.45, "ask": 4.6, "bidSize": 1, "askSize": 1, "marketCap": 931658432, "fiftyTwoWeekLow": 2.111, "fiftyTwoWeekHigh": 7.983, "allTimeHigh": 19.064, "allTimeLow": 1.53, "priceToSalesTrailing12Months": 54.900322, "fiftyDayAverage": 4.3198, "twoHundredDayAverage": 4.12432, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 682385664, "profitMargins": 0.0, "floatShares": 101381444, "sharesOutstanding": 191017947, "sharesShort": 87064, "sharesShortPriorMonth": 285615, "sharesShortPreviousMonthDate": 1763078400, "dateShortInterest": 1765756800, "sharesPercentSharesOut": 0.0005, "heldPercentInsiders": 0.0, "heldPercentInstitutions": 0.0765, "shortRatio": 0.43, "shortPercentOfFloat": 0.0005, "impliedSharesOutstanding": 192889953, "bookValue": -0.07460608, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -311064992, "trailingEps": -4.39, "forwardEps": -1.3125, "enterpriseToRevenue": 40.211, "enterpriseToEbitda": -7.124, "52WeekChange": 1.267281, "SandP52WeekChange": 0.18594909, "quoteType": "EQUITY", "currentPrice": 4.83, "targetHighPrice": 26.0, "targetLowPrice": 3.0, "targetMeanPrice": 15.0005, "targetMedianPrice": 13.5, "recommendationMean": 1.1, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 10, "totalCash": 122513000, "totalCashPerShare": 0.88, "ebitda": -95789000, "totalDebt": 132798000, "quickRatio": 2.486, "currentRatio": 2.956, "totalRevenue": 16970000, "revenuePerShare": 0.192, "returnOnAssets": -0.56769, "grossProfits": 16153000, "freeCashflow": -77385752, "operatingCashflow": -91311000, "revenueGrowth": 1.052, "grossMargins": 0.95185995, "ebitdaMargins": 0.0, "operatingMargins": -9.91889, "financialCurrency": "EUR", "symbol": "IVA", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "postMarketTime": 1768006432, "regularMarketTime": 1767992401, "exchange": "NGM", "messageBoardId": "finmb_273516426", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "shortName": "Inventiva S.A. - American Depos", "epsTrailingTwelveMonths": -4.39, "epsForward": -1.3125, "epsCurrentYear": -1.98917, "priceEpsCurrentYear": -2.4281485, "fiftyDayAverageChange": 0.5102, "fiftyDayAverageChangePercent": 0.11810733, "twoHundredDayAverageChange": 0.7056799, "priceToBook": -64.74003, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-07-10", "averageAnalystRating": "1.1 - Strong Buy", "cryptoTradeable": false, "regularMarketChangePercent": -1.82927, "regularMarketPrice": 4.83, "corporateActions": [], "longName": "Inventiva S.A.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1594387800000, "postMarketChangePercent": -0.2070342, "postMarketPrice": 4.82, "postMarketChange": -0.009999752, "regularMarketChange": -0.0900002, "regularMarketDayRange": "4.77 - 4.9", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 318355, "fiftyTwoWeekLowChange": 2.7189999, "fiftyTwoWeekLowChangePercent": 1.288015, "fiftyTwoWeekRange": "2.111 - 7.983", "fiftyTwoWeekHighChange": -3.1529999, "fiftyTwoWeekHighChangePercent": -0.3949643, "fiftyTwoWeekChangePercent": 126.7281, "earningsTimestampStart": 1759149000, "earningsTimestampEnd": 1759149000, "earningsCallTimestampStart": 1743076800, "earningsCallTimestampEnd": 1743076800, "isEarningsDateEstimate": false, "twoHundredDayAverageChangePercent": 0.17110212, "marketState": "CLOSED", "displayName": "Inventiva", "trailingPegRatio": null, "__fetch_time": "2026-01-10"}]